Retrospective observational study on the effect of vedolizumab treatment on patients with inflammatory bowel disease and extraintestinal manifestations. The EMOTIVE study First published 11/10/2018 Last updated 23/04/2024 EU PAS number:EUPAS25761 Study Finalised